Следене
Dimitar Kalev
Dimitar Kalev
Associete Professor, Medical University - Varna
Потвърден имейл адрес: kalevi.eu
Заглавие
Позовавания
Позовавания
Година
Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a …
A Di Leo, S Johnston, KS Lee, E Ciruelos, PE Lønning, W Janni, ...
The Lancet Oncology 19 (1), 87-100, 2018
3822018
Abstract S4-07: BELLE-3: a phase III study of buparlisib+ fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic …
A Di Leo, K Seok Lee, E Ciruelos, P Lønning, W Janni, R O'Regan, ...
Cancer Research 77 (4_Supplement), S4-07-S4-07, 2017
612017
Namodenoson in advanced hepatocellular carcinoma and Child–Pugh B cirrhosis: randomized placebo-controlled clinical trial
SM Stemmer, NS Manojlovic, MV Marinca, P Petrov, N Cherciu, D Ganea, ...
Cancers 13 (2), 187, 2021
262021
A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A3 adenosine receptor agonist (A3AR …
SM Stemmer, NS Manojlovic, MV Marinca, P Petrov, N Cherciu, D Ganea, ...
Journal of Clinical Oncology 37 (15_suppl), 2503-2503, 2019
102019
CECOG experts’ recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer
W Hilbe, U Abacioglu, DM Aebersold, M Bachouchi, T Brodowicz, ...
memo-Magazine of European Medical Oncology 6, 75-82, 2013
22013
First line 5-FU-based chemotherapy with/without bevacizumab for metastatic colorectal cancer: one center experience results
A Konsoulova, I Donev, N Conev, S Draganova, T Chervenkov, N Petrova, ...
Scripta Scientifica Medica 47, 20-25, 2015
2015
2-year single center clinical experience in patients with colon cancer stage II and III receiving adjuvant chemotherapy
NV Conev, IS Donev, E Dimitrova, M Kozhuharova, M Georgieva, ...
Scripta Scientifica Medica 47 (2), 43-48, 2015
2015
Personalized medication therapy in patients with aN advanced lung adenocarcinoma
E Dimitrova, D Kalev
Scripta Scientifica Medica 46 (1), 2014
2014
Abstracts of the 20th annual meeting of the associationHeart-Lungand 2nd †žVarna-Augsburgconference 30-31 may 2014
P Manoilov, P Panayotov, K Yankov, E Dimitrova, D Kalev, Y Krasnaliev, ...
Scripta Scientifica Medica 46 (1), 1-42, 2014
2014
Functional Results and Oncological Outcome of Radical Prostatectomy Used as a Primary Treatment in Locally Advanced Prostate Cancer
A Hinev, D Anakievski, V Hadjiev, A Angelov, L Marinova, D Kalev
UROLOGY 80 (3), S272-S272, 2012
2012
Impact of seminal vesicle invasion on oncological outcome after radical prostatectomy
DK Hinev A., I. Krasnaliev, L. Marinova
Urology 74 (Suppl 4A), S132, 2009
2009
Cell adhesion molecules in pleural effusions with different etiology
I Micheva, D Kalev, G Georgiev
Biomedical Reviews 6, 121-123, 1996
1996
DIAGNOCTIC ALGORITHM FOR BRONCHIAL ASTHMA
S Projkov, M Peneva, Z Zlatanov, D Kalev
Scripta Scientifica Medica 28, 35-36, 1991
1991
BRONCHOALVEOLAR LAVAGE IN THE DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF LUNG DISEASES
H Ganchev, M Kokoshyan, D Kalev
Scripta Scientifica Medica 28, 39-40, 1991
1991
LITERARY EMERGENTISM
D KALEV
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–15